Live Breaking News & Updates on Food Intolerance|Page 12
Stay updated with breaking news from Food intolerance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Food intolerance group to double workforce as it expands FoodMarble breath test app helps people identify foods that could trigger symptoms Sun, Feb 28, 2021, 14:41
Digital digestive health start-up FoodMarble is to create 25 jobs as part of its continued expansion. The recruitment comes after the Dublin-based company raised $2.6 million (€2.1 million) in funding to grow its at-home digestive health solution and move into new markets. The company is exploring new markets in addition to new research and development projects and its personal digestive tracker, FoodMarble AIRE. “Our continued expansion plans and the hiring of 25 roles, doubling the size of our team, is a really exciting step and will help us continue to execute on our mission and capture new markets,” said chief executive Aonghus Shortt. ....
Health Food Market Still Has Room To Grow: Hain Celestial, PepsiCo, Keurig Green Mountain texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Marston's PLC shares lose their froth as US bidder backs away proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces the appointment of Dr Simon Douglas as independent Non-Executive Chairman. Simon has been appointed to the Board with immediate effect, after a thorough search process that was conducted with the help of Snedden Campbell Ltd. Simon has also become a member of both the Audit Committee and the Remuneration Committee.
Simon has 25 years of Board level experience at both early stage and public businesses within the Diagnostics, Life Science and BioPharma industries. Simon is currently Non-Executive Chairman at AIM listed Fusion Antibodies plc, having previously served as its Chief Executive Officer up until 2011. Simon is also Non-Executive Chairman of C-Major Medical, a private limited company. Simon holds a PhD in in-vivo Diagnostics and an MPhil in Immunology, both from the University of Southampton. ....